乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

AAAAI

<乌鸦传媒>Investigational Biologic Shows Efficacy for HAE Prophylaxis

Once-a-month drug had a big impact on attack rates

<乌鸦传媒>Real-World Data Confirm Early Peanut Feeding Benefit for High-Risk Infants

But caregivers reported that following the feeding protocol was not always easy

<乌鸦传媒>Mepolizumab Reduces Need for Oral Steroids in Severe Asthma

Some adults on the IL-5 antibody were able to stop taking systemic steroids

<乌鸦传媒>Docs Debate Home Spirometry

Is it ready for prime time or is it just a toy with possible serious consequences?

<乌鸦传媒>Does One Mab Come Out on Top for Boosting Lung Function in Asthma?

Dupilumab edges out other biologics, but differences were small in indirection comparison

<乌鸦传媒>Mepolizumab Cuts Asthma Flare-Ups in Disadvantaged Kids

Black and Hispanic children living in urban settings benefited from biologic therapy

<乌鸦传媒>Many Severe Asthma Patients Achieve Remission on Biologics

Year-long freedom from exacerbations without steroids reported in real-world study

<乌鸦传媒>Tezepelumab Benefits Asthma Patients Year-Round

Biologic consistently reduced the annualized asthma exacerbation rate

<乌鸦传媒>Medical Approach May Work in Nasal Polyps With Asthma

Omalizumab improves polyp symptom scores with low recurrence rate

<乌鸦传媒>Glimpses of Hope for Lebrikizumab in Asthma

Subgroup targeting may hold promise for biologic

<乌鸦传媒>One Nutty Gene: Peanut Oral Immunotherapy Outcomes Affected by HLA Allele

Carriers of immune system gene variant show better response to treatment

<乌鸦传媒>Dupilumab May Help in Tough-to-Treat Chronic Spontaneous Urticaria

Add-on IL inhibitor to H1-antihistamine offers "promising, novel treatment option"

<乌鸦传媒>Dupilumab Continues to Show Promise in Eosinophilic Esophagitis

Almost 60% of patients in LIBERTY EoE TREET study achieved remission

<乌鸦传媒>Black, Latinx Adults With Asthma Benefit From Inhaled Glucocorticoid Add-On

"Shovel-ready" intervention can help reduce disparities in asthma burden, researchers say

<乌鸦传媒>Minority Participation in Food Allergy Trials Remains Low

Increasing participation is a significant unmet challenge, researcher says

<乌鸦传媒>Peanut SLIT Seems Safe, Effective in Toddlers

Sustained responses were common and symptoms tied to SLIT were mild

<乌鸦传媒>No Special Risk for Severe COVID in Asthma

Indeed, could it be actually protective?

<乌鸦传媒>Studies Cast More Light on 'Long COVID' Prevalence, Presentation

High rates of debilitating symptoms lasting months

<乌鸦传媒>More Support for Early Peanut Intro to Reduce Allergy Risk

"Dramatic" decline in prevalence after feeding shift in Australia, study shows

<乌鸦传媒>Pandemic Crushes Uptake of Peanut Immunotherapy

Promising data on Palforia and Viaskin Peanut, but challenges persist

<乌鸦传媒>AAAAI: Restaurant EpiPens; Devices OK After Expiration? How About After Laundering?

Roundup of epinephrine injector research prepared for AAAAI 2020

<乌鸦传媒>In Chronic Urticaria, Staying on Treatment Matters

55% of patients who stopped taking omalizumab saw return of symptoms

<乌鸦传媒>Breathing Problems From Aspirin? Help is Here

Encouraging results with desensitization protocol, nasal polyp removal

<乌鸦传媒>Asthma More Common in Opioid-Dependent Patients

Also, women taking opioids have greatest asthma risk

<乌鸦传媒>Eczema Risk at School Age May be Lower in Breastfed Kids

Nursing may play a protective role in decreasing the chronicity of eczema in childhood, researchers say

<乌鸦传媒>Folic Acid in Utero Tied to Food Allergy Risk

But total folate at birth not associated with later food allergies

<乌鸦传媒>AAAAI: Penicillin Allergy Label Linked to MRSA, C. difficile

Increase attributable to use of alternative antibiotics

<乌鸦传媒>Alpha-Gal Challenges Food Allergy Paradigm

Research looks at ties between red-meat allergy and venom allergens

<乌鸦传媒>AAAAI: No Benefit to Upping Inhaled Steroids During Asthma 'Yellow Zone'

Increasing dosage even by factor of four to five did not prevent exacerbations

<乌鸦传媒>Do Results from Peanut Allergy Trials Last Long-Term?

Kids showed high anaphylaxis rate with at-home challenge

<乌鸦传媒>Asthma App Disappoints for Cutting Urgent Care Use

No drop in healthcare utilization in high-risk kids

<乌鸦传媒>Mixed Infant Feeding May Up Risk for Food Allergy

Problem may be with multiple sources of allergens

<乌鸦传媒>Mom's Vitamin E Levels Tied to Child's Risk for Asthma

But study results do not justify high-dose supplementation

<乌鸦传媒>Disease Outbreaks Don't Care Who's President, NIAID Head Says

Anthony Fauci, MD, warns Trump's team about infectious disease challenges

<乌鸦传媒>AAAAI: Drug Hypersensitivity in the Spotlight

Also, get ready for the great peanut debate at annual meeting

<乌鸦传媒>Xolair May Reduce Rate of Cold Symptoms in Asthmatic Kids

Study assessed omalizumab paired with guideline-based treatment

<乌鸦传媒>Patients Often Overstate Penicillin Allergy

Inpatient skin-testing protocol led to removal of allergy label in majority of cases

<乌鸦传媒>Severe Eczema Eases with Novel Biologic

SAN DIEGO -- The novel monoclonal antibody dupilumab dramatically cut the severity of moderate-to-severe adult atopic dermatitis, a phase II trial showed.

<乌鸦传媒>Spiriva Cuts Flares in Heavily Treated Asthma

SAN DIEGO -- Tiotropium (Spiriva) Respimat improved lung function and cut exacerbations in severe asthma patients who had already maxed out other treatment options, pooled analysis of two phase III trials showed.

<乌鸦传媒>Patch May Be Safer Peanut Allergy Therapy

SAN DIEGO -- A skin patch offered peanut-allergy immunotherapy without risk of systemic reactions but also with questionable efficacy, a pilot trial showed.

1